Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

1.74
Delayed Data
As of 10:25am ET
 +0.036 / +2.12%
Today’s Change
1.52
Today|||52-Week Range
3.50
-46.25%
Year-to-Date

Today’s Trading

Previous close1.70
Today’s open1.70
Day’s range1.70 - 1.75
Volume62,965
Average volume (3 months)329,997
Market cap$81.2M
Dividend yield--
Data as of 10:25am ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+38.89%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
NAVBNavidea Biopharmaceu...-0.00-0.78%
OHRPOHR Pharmaceutical I...+0.05+1.88%
EPIXESSA Pharma Inc0.000.00%
ABEOAbeona Therapeutics ...+0.03+1.12%
Data as of 10:43am ET, 07/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$21.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs